Charles Carignan MD
Chuck brings over 20 years of experience in medical device development. He has vast experience as a clinician, med-tech executive and CEO. He has had the opportunity to introduce a number of breakthrough technologies that have changed healthcare, navigating the clinical, regulatory and reimbursement challenges along the way. Before joining Rex Bionics he was the CEO of BionX (sold to Ottobock), and was founder and CEO of Ninepoint Medical, a developer of medical devices that enable high resolution in-vivo imaging. At NinePoint, he was able to bring together an outstanding team who developed and launched the first product within 3 years of licensing the fundamental technology from Massachusetts General Hospital. Prior to that, Chuck was Executive Vice President and Chief Medical Officer of Novasys Medical, Inc., where he was responsible for the successful launch of a device to treat stress urinary incontinence. Prior to Novasys, he was Chief Medical Officer at Boston Scientific, and Vice President of clinical research and medical affairs at Conceptus. Chuck has served healthcare worldwide participating on committees of the U.S. Food and Drug Administration, Centers for Medicare & Medicaid Services, the World Health Organization, the United Nations, and the U.S. Agency for International Development. Chuck trained in general surgery at Columbia-Presbyterian Medical Center. He earned his undergraduate degree from Yale University and his MD degree from the College of Physicians and Surgeons of Columbia University. Chuck joined Rex Bionics in June 2017.